术前MRE无创评估肝细胞癌侵袭性血管表型及早期复发
该前瞻性研究纳入220例拟行肝切除的肝细胞癌患者,术前使用MR弹性成像定量肿瘤硬度与黏度。研究发现MRE力学参数可独立预测VETC、MTM、MVI及2年早期复发,联合MRE后预测早期复发的AUC从0.798提升至0.834。
要点
- 肿瘤黏度升高是MTM独立预测因子,联合临床影像模型AUC可达0.748。
- 肿瘤硬度升高提示VETC可能,肿瘤较软则与MVI阳性相关。
- MRE参数加入后预测术后2年复发效能显著优于单纯临床影像模型。
核心结论
- MRE衍生的力学指标可用于肝细胞癌侵袭性表型及术后早期复发的术前风险分层。
- 肿瘤黏度升高提示MTM,肿瘤硬度升高提示VETC,肿瘤较软提示MVI阳性。
研究设计与样本
- 前瞻性队列研究,220例拟行肝切除的肝细胞癌患者术前1周内接受MRE检查。
- MRE定量参数包括组织硬度与黏度,以术后病理评估VETC、MTM、MVI及2年复发为终点。
- 采用多因素logistic回归筛选独立预测因子,并以AUC评价模型效能。
关键影像表现/征象
- MTM组肿瘤黏度显著高于非MTM组(1.171 rad 对比 0.900 rad,p=0.002)。
- MRE示肿瘤硬度升高与VETC相关,肿瘤较软与MVI阳性相关。
- MRI影像征象中,瘤周强化是早期复发独立指标,非光滑边缘提示MTM及MVI。
- 肿瘤包膜完整与VETC独立相关,包膜不完整或缺失与MVI阳性独立相关。
- 多灶性与MVI阳性独立相关。
诊断标准与关键数值
- 早期复发独立预测因子:VETC的OR为2.320(p=0.046),MTM的OR为2.573(p=0.024),MVI的OR为2.613(p=0.035),肝硬度升高的OR为3.257(p=0.015),CA125>24 U/mL的OR为4.742(p=0.010),瘤周强化的OR为2.351(p=0.040)。
- 含MRE的模型预测早期复发AUC为0.834,高于不含MRE模型的0.798(DeLong检验,p<0.001)。
- MTM独立预测因子:肿瘤黏度升高OR为1.449(p=0.017),男性OR为8.475(p=0.001),AFP升高OR为1.980(p=0.002),非光滑边缘OR为2.693(p=0.002)。
- 含MRE模型预测MTM的AUC为0.748,高于不含MRE模型的0.706(p=0.009)。
- VETC独立预测因子含肿瘤更硬OR为1.567(p=0.042),模型AUC为0.747对比非MRE模型0.710(p=0.078)。
临床应用与阅片要点
- 对拟手术肝细胞癌患者,术前MRE增加的肿瘤硬度与黏度信息应纳入复发风险分层判断。
- 肿瘤黏度升高时需警惕MTM亚型,并在报告中提示术后早期复发风险。
- 肿瘤硬度升高提示VETC,肿瘤较软且伴多灶、包膜不完整或边缘不光滑需关注MVI阳性。
- 瘤周强化、非光滑边缘、包膜状态应与MRE力学参数联合解读以提升预测效能。
局限性
- MRE预测VETC与MVI的AUC提高未达到统计学显著性(p值分别为0.078和0.068)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To differentiate vessel-encapsulating tumor clusters (VETC), microvascular invasion (MVI), macrotrabecular-massive (MTM), and early recurrence using preoperative MR elastography (MRE) in hepatocellular carcinoma (HCC).
METHODS: 220 HCC patients scheduled for hepatectomy were prospectively recruited, with preoperative MRE quantifying tissue stiffness and viscosity. Multivariate logistic regression identified independent predictors, evaluated by an area under the curve (AUC).
RESULTS: 78 of 220 patients encountered postoperative 2-year relapse. VETC (odds ratio [OR] 2.320, p = 0.046), MTM (OR 2.573, p = 0.024), MVI (OR 2.613, p = 0.035), elevated liver stiffness (OR 3.257, p = 0.015), carbohydrate antigen 125 > 24 U/mL (OR 4.742, p = 0.010), and peritumoral enhancement (OR 2.351, p = 0.040) were independent indicators of early recurrence, which was higher than that without MRE (AUC = 0.834 vs. 0.798, DeLong test, p < 0.001). Increased tumor viscosity (OR 1.449, p = 0.017), men (OR 8.475, p = 0.001), elevated alpha-fetoprotein levels (OR 1.980, p = 0.002), and non-smooth margin (OR 2.693, p = 0.002) were independent predictors of MTM, significantly higher than the non-MRE model (AUC = 0.748 vs. 0.706, p = 0.009). MTM exhibited significantly higher tumor viscosity (1.171 vs. 0.900 rad, p = 0.002) but looser cell junction proteins than non-MTM: E-cadherin (10.440% vs. 19.685%, p = 0.001), Occludins (14.521% vs. 27.029%, p = 0.001), and ZO-1 (5.875% vs. 8.083%, p = 0.046). Additionally, stiffer tumor (OR 1.567, p = 0.042), male (OR 4.102, p = 0.002), alanine aminotransferase > 64 U/L (OR 2.801, p = 0.049), elevated alpha-fetoprotein levels (OR 2.359, p < 0.001), and tumor capsule (OR 3.101, p = 0.012) were markedly indicative of VETC (AUC = 0.747 vs. non-MRE 0.710, p = 0.078). Conversely, softer tumor (OR 1.887, p = 0.045), multifocality (OR 3.881, p = 0.002), incomplete or absent capsule (OR 3.746, p < 0.001), and non-smooth margin (OR 6.771, p < 0.001) were independently associated with MVI-positivity (AUC = 0.864 vs. non-MRE 0.841, p = 0.068).
CONCLUSIONS: MRE-derived mechanical biomarkers are instrumental in risk stratification of aggressive HCC phenotypes and relapse.
引用
- Chong, Rui, Deng, et al. Preoperative MR elastography for characterizing aggressive vascular phenotypes in hepatocellular carcinoma. Eur J Radiol. 2026. PMID: 42520380. doi:10.1016/j.ejrad.2026.113071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。